Epigallocatechin-3-Gallate (EGCG) Attenuates Traumatic Brain Injury by Inhibition of Edema Formation and Oxidative Stress

Traumatic brain injury (TBI) is a major cause of mortality and long-term disability, which can decrease quality of life. In spite of numerous studies suggesting that Epigallocatechin-3-gallate (EGCG) has been used as a therapeutic agent for a broad range of disorders, the effect of EGCG on TBI remai...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Bo, Wang, Bing, Cao, Shuhua, Wang, Yongqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Physiological Society and The Korean Society of Pharmacology 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4637351/
https://www.ncbi.nlm.nih.gov/pubmed/26557015
http://dx.doi.org/10.4196/kjpp.2015.19.6.491

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4637351/
https://www.ncbi.nlm.nih.gov/pubmed/26557015
http://dx.doi.org/10.4196/kjpp.2015.19.6.491

Ejemplares similares